利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

2678 条记录 (耗时 0.046 秒)

    SYSTEMS, DEVICES, AND METHODS FOR ANALYTE MONITORING
    15.
    发明公开
    SYSTEMS, DEVICES, AND METHODS FOR ANALYTE MONITORING 审中-公开

    公开(公告)号：US20240252065A1

    公开(公告)日：2024-08-01

    申请号：US18422837

    申请日：2024-01-25

    申请人： ABBOTT DIABETES CARE INC.

    发明人： Peter G. Robinson ,  Timothy F. Smith

    IPC分类号： A61B5/145

    CPC分类号： A61B5/14503 ,  A61B2560/0462

    摘要： An analyte monitoring system including an electronics housing including a shell having a first aperture and a welding portion proximate the first aperture, the welding portion including an infrared transmissive material, a mount having a second aperture axially aligned with the first aperture, wherein the mount is configured to be secured to the shell to define an interior space, a collar disposed within the interior space and having a central aperture axially aligned with the first aperture and the second aperture, and a first collapsible rib on a first side, the first collapsible rib axially aligned with the welding portion and including an infrared absorbent material, wherein the first collapsible rib is configured to weld to the welding portion, a circuit board disposed within the interior space, and an analyte sensor having a distal portion and a proximal portion.

    Analyte sensors employing multiple enzymes and methods associated therewith
    16.
    发明授权
    Analyte sensors employing multiple enzymes and methods associated therewith 有权

    公开(公告)号：US12048539B2

    公开(公告)日：2024-07-30

    申请号：US16774841

    申请日：2020-01-28

    申请人： Abbott Diabetes Care Inc.

    发明人： Stephen Oja ,  Tianmei Ouyang ,  Hyun Cho ,  Benjamin J. Feldman ,  Namvar Kiaie

    IPC分类号： A61B5/1486 ,  A61B5/145 ,  C12Q1/00

    CPC分类号： A61B5/14865 ,  A61B5/14532 ,  C12Q1/002 ,  C12Q1/005 ,  G01N2333/9029 ,  G01N2333/904 ,  G01N2333/908

    摘要： Multiple enzymes may be present in the active area(s) of an electrochemical sensor to facilitate analysis of one or more analytes. The multiple enzymes may function independently to detect several analytes or in concert to detect a single analyte. One sensor configuration includes a first active area and a second active area, where the first active area has an oxidation-reduction potential that is sufficiently separated from the oxidation-reduction potential of the second active area to allow independent signal production. Some sensor configurations may have an active area overcoated with a multi-component membrane containing two or more different membrane polymers. Sensor configurations having multiple enzymes capable of interacting in concert include those in which a first enzyme converts an analyte into a first product and a second enzyme converts the first product into a second product, thereby generating a signal at a working electrode that is proportional to the analyte concentration.

    SYSTEMS, DEVICES, AND METHODS RELATING TO MEDICATION DOSE GUIDANCE
    19.
    发明公开
    SYSTEMS, DEVICES, AND METHODS RELATING TO MEDICATION DOSE GUIDANCE 审中-公开

    公开(公告)号：US20240225535A1

    公开(公告)日：2024-07-11

    申请号：US18511003

    申请日：2023-11-16

    申请人： ABBOTT DIABETES CARE INC.

    发明人： Matthew T. Novak ,  Aparajita Bhattacharya ,  Gary A. Hayter

    IPC分类号： A61B5/00 ,  A61B5/145 ,  G16H50/70 ,  G16H70/40

    CPC分类号： A61B5/4839 ,  A61B5/0022 ,  A61B5/14532 ,  G16H50/70 ,  G16H70/40

    摘要： Systems, devices and methods are provided for titration of a medication dose for a patient or user. The titration may be based on determining a hypoglycemic risk of a user for a plurality of time-of-day periods. The determination of the hypoglycemic risk may be accomplished by known methods, including the glucose pattern analysis, glucose dysregulation analysis, low alarm frequency analysis, and combinations thereof. The system may then select a recommended action based on the analyte pattern type. The system may then store an indicator of the recommended action in a computer memory for output. The system may then output the recommended action. The recommended action may be outputted to the user, an HCP, or a caregiver. The recommended action may also vary depending on who is receiving the recommended action.